BioConnection BioConnection BioConnection

BioConnection

A CDMO for injectable (bio)pharmaceutical products

BioConnection is a niche contract development and manufacturing organisation (CDMO) focused on fill and finish and freeze-drying of injectable (bio)pharmaceutical products. The company operates from its FDA- & GMP-approved manufacturing site in Oss (the Netherlands) and is one of the few niche players with both clinical and commercial manufacturing capabilities.

Healthcare

Visit website

Investment  details

Entry

2022

Staff

Location

Netherlands

Gimv's partnership with BioConnection is driven by our shared vision of the evolving pharmaceutical industry. We're committed to enhancing development and manufacturing capabilities to meet growing demand for specialised drug delivery, complex biologics, and niche treatments.

Alexander Willemse

CEO

Partnership Gimv Partnership Gimv Partnership Gimv

Partnership Gimv

Gimv supports BioConnection, as the pharmaceutical industry is moving towards specialised drug delivery, complex biologics, and niche treatments, which necessitates enhanced development and manufacturing capabilities. BioConnection anticipates substantial investments to maintain high service quality. Gimv's backing involves further investments to expand BioConnection's organisation and infrastructure, ultimately boosting production capacity and service offerings to align with the evolving pharmaceutical landscape.